Research Articles

Studies of the neurotoxicity of oral artemisinin derivatives in mice

Intramuscular injections of high doses of the oil-soluble antimalarial artemisinin derivatives artemether and arteether produce an unusual pattern of selective damage to brain stem centers in experimental mammals, predominantly those involved in auditory processing and vestibular reflexes. We have shown recently in adult Swiss albino mice that parenteral artesunate, a water-soluble derivative, is significantly less neurotoxic than intramuscular artemether in this murine model. Using the same model, in which the drugs were administered daily for 28 days, the neurotoxic potential of the oral drugs was assessed and compared with the parenteral routes of administration. The dose causing neurotoxicity or death in 50% of animals (ED50), was approximately 300 mg/kg/day of oral artemether and artesunate compared to 50 mg/kg/day of intramuscular artemether. Doses of intramuscular artemether > 100 mg/kg/day were uniformly lethal. When oral artemether was given in peanut oil there was an increase in neurotoxicity and mortality compared with the aqueous suspension (P = 0.002), and when the food pellets were coated with artemether in oil, giving relatively constant oral intake, neurotoxicity was further increased; ED50 = 150 mg/kg/day (P = 0.017). These data indicate that once-daily oral administration of artesunate or artemether is relatively safe, presumably because the central nervous system is exposed transiently, whereas constant exposure either from depot intramuscular injection of oil-based drug, or constant oral intake carries relatively greater neurotoxic potential.

This article has been cited by other articles:

				M. Spicher, C. Roethlisberger, C. Lany, B. Stadelmann, J. Keiser, L. M. Ortega-Mora, B. Gottstein, and A. Hemphill In Vitro and In Vivo Treatments of Echinococcus Protoscoleces and Metacestodes with Artemisinin and Artemisinin Derivatives Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3447 - 3450. [Abstract] [Full Text] [PDF]

				P. J. Rosenthal Artesunate for the Treatment of Severe Falciparum Malaria N. Engl. J. Med., April 24, 2008; 358(17): 1829 - 1836. [Full Text] [PDF]

				F. Nosten and N. J. White Artemisinin-Based Combination Treatment of Falciparum Malaria Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 181 - 192. [Abstract] [Full Text] [PDF]

				E. Fattorusso, S. Parapini, C. Campagnuolo, N. Basilico, O. Taglialatela-Scafati, and D. Taramelli Activity against Plasmodium falciparum of cycloperoxide compounds obtained from the sponge Plakortis simplex J. Antimicrob. Chemother., December 1, 2002; 50(6): 883 - 888. [Abstract] [Full Text] [PDF]

				B. J. Angus, I. Thaiaporn, K. Chanthapadith, Y. Suputtamongkol, and N. J. White Oral Artesunate Dose-Response Relationship in Acute Falciparum Malaria Antimicrob. Agents Chemother., March 1, 2002; 46(3): 778 - 782. [Abstract] [Full Text] [PDF]